Molecular imaging of human tumor cells that naturally overexpress type 2 cannabinoid receptors using a quinolone-based near-infrared fluorescent probe

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Biomedical Optics

• Publication date

  2014-07-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1117/1.JBO.19.7.076016PMID 25036213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probe.

  2013cited by this paper
• Preparation of semisynthetic lipoproteins with fluorescent cholesterol anchor and their introduction to the cell membrane with minimal disruption of the membrane.

  2013cited by this paper
• Targeted zwitterionic near-infrared fluorophores for improved optical imaging

  2013cited by this paper
• Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence

  2013cited by this paper
• Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies

  2012cited by this paper
• Recent advances in receptor-targeted fluorescent probes for in vivo cancer imaging.

  2012cited by this paper
• Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy.

  2012cited by this paper
• Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking

  2012cited by this paper
• Chronic blockade of cannabinoid CB2 receptors induces anxiolytic‐like actions associated with alterations in GABAA receptors

  2012cited by this paper
• Getting to the core of addiction: Hooking CB2 receptor into drug abuse?

  2012cited by this paper
• Cannabinoids: a new hope for breast cancer therapy?

  2012cited by this paper
• Investigations on the 4‐Quinolone‐3‐Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid‐2 Receptor Ligands through a Bioisosteric Approach

  2012cited by this paper
• Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

  2011cited by this paper
• Colonoscopy and optical biopsy: bridging technological advances to clinical practice.

  2011cited by this paper
• Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice

  2011cited by this paper
• Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy

  2011cited by this paper
• Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice

  2011cited by this paper
• NIR-mbc94, a fluorescent ligand that binds to endogenous CB(2) receptors and is amenable to high-throughput screening.

  2011cited by this paper
• Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies

  2011cited by this paper
• Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results.

  2011cited by this paper
• Cannabinoid/agonist WIN 55,212‐2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS

  2011cited by this paper
• Investigations on the 4-quinolone-3-carboxylic acid motif. 4. Identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice.

  2011cited by this paper
• Molecular imaging: interaction between basic and clinical science.

  2010cited by this paper
• THEMED ISSUE: CANNABINOIDS REVIEW The endocannabinoid system as a target for the treatment of neurodegenerative disease

  2010cited by this paper
• The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas

  2010cited by this paper
• Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non–Small Cell Lung Cancer Growth and Metastasis

  2010cited by this paper
• Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age

  2010cited by this paper
• Non-invasive imaging of the type 2 cannabinoid receptor, focus on positron emission tomography.

  2010cited by this paper
• Evidence that MDMA (‘ecstasy’) increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain

  2010cited by this paper
• Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.

  2010cited by this paper
• Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

  2009cited by this paper
• Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2

  2009cited by this paper
• Antitumoural effect of cannabinoids in an animal model of breast cancer

  2008cited by this paper
• Cannabinoid Receptor Activation Induces Apoptosis through Tumor Necrosis Factor α–Mediated Ceramide De novo Synthesis in Colon Cancer Cells

  2008cited by this paper
• Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma

  2008cited by this paper
• Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo.

  2008cited by this paper
• MBC94, a conjugable ligand for cannabinoid CB 2 receptor imaging.

  2008influential reference
• Cannabinoids and Gliomas

  2007cited by this paper
• Cannabinoid receptors as novel targets for the treatment of melanoma

  2006cited by this paper
• The Endocannabinoid System as an Emerging Target of Pharmacotherapy

  2006cited by this paper
• Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

  2006cited by this paper
• Evidence for the Involvement of the Cannabinoid CB2 Receptor and Its Endogenous Ligand 2-Arachidonoylglycerol in 12-O-Tetradecanoylphorbol-13-acetate-induced Acute Inflammation in Mouse Ear*

  2005cited by this paper
• Cannabinoid receptor as a novel target for the treatment of prostate cancer.

  2005cited by this paper
• Prevention of Alzheimer's Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation

  2005cited by this paper
• Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

  2003cited by this paper
• Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

  2003cited by this paper
• In vivo near-infrared fluorescence imaging.

  2003cited by this paper
• Cannabinoids and multiple sclerosis.

  2002cited by this paper
• Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.

  2002cited by this paper
• Cannabinoid receptors and their ligands.

  2002cited by this paper
• In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor.

  2001cited by this paper
• Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.

  2001cited by this paper
• SCIENTIFIC NOTE: Fluorescence properties of indocyanine green as related to angiography

  1978cited by this paper

• Exploring 4-quinolone-3-carboxamide derivatives: A versatile framework for emerging biological applications.

  2025cites this paper
• N-Adamantyl-1-alkyl-4-oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as Fluorescent Probes to Detect Microglia Activation through the Imaging of Cannabinoid Receptor Subtype 2 (CB2R).

  2024cites this paper
• Rational Design, Synthesis, and Evaluation of Fluorescent CB2 Receptor Ligands for Live-Cell Imaging: A Comprehensive Review

  2023cites this paper
• A Late-Stage Aryl C-H Olefination Strategy and Its Application Towards Global Proteome Profiling of ∆8-Tetrahydrocannabinol.

  2023cites this paper
• RETRACTED: Fluorescent and Phosphorescent Nitrogen-Containing Heterocycles and Crown Ethers: Biological and Pharmaceutical Applications

  2022cites this paper
• Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy.

  2022cites this paper
• Design and Application of Receptor-Targeted Fluorescent Probes Based on Small Molecular Fluorescent Dyes.

  2021cites this paper
• Functionalized Cannabinoid Subtype 2 Receptor Ligands: Fluorescent, PET, Photochromic and Covalent Molecular Probes

  2020cites this paper
• Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R).

  2020cites this paper
• The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020

  2020cites this paper
• The Role of Cannabinoids in Allergic Diseases

  2020cites this paper
• Quinolones as prospective drugs: Their syntheses and biological applications

  2020cites this paper
• Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold.

  2018cites this paper
• Molecular Imaging of Pancreatic Duct Adenocarcinoma Using a Type 2 Cannabinoid Receptor-Targeted Near-Infrared Fluorescent Probe

  2018cites this paper
• Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors

  2017cites this paper
• Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

  2017cites this paper
• The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory

  2016cites this paper
• The cannabinoid type-2 (CB2) receptor as a target for anti-inflammatory disease modification in Parkinson's disease

  2016cites this paper
• A novel near-infrared fluorescence imaging probe that preferentially binds to cannabinoid receptors CB2R over CB1R.

  2015cites this paper
• Chapter 8 Summary and Future Prospects

  year unknowncites this paper
• Chemical tools to study the cannabinoid receptor type 2

  year unknowncites this paper